Literature DB >> 23812642

Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality.

F Palm1, N Henschke, J Wolf, K Zimmer, A Safer, R J Schröder, G Inselmann, C Brenke, H Becher, A J Grau.   

Abstract

Data on incidence of intracerebral haemorrhage (ICH) vary widely. Population-based data on predictors of ICH survival and functional outcome are rare. The Ludwigshafen Stroke Study is a prospective, population-based stroke registry which started in January 2006. All residents of the city of Ludwigshafen, Germany, who suffer from acute stroke or transient ischaemic attack are registered. Patients with first-ever primary intracerebral haemorrhage (FE-pICH) between 2006 and 2010 were included in the present analysis. Between January 1st, 2006 and December 31st, 2010, 152 patients suffered a FE-pICH. Crude and age-adjusted incidence rates per 100,000 for FE-pICH were 18.7 (95 % CI 15.9-21.9) and 11.9 (95 % CI 10.2-14.0), respectively, and remained stable over time. Case-fatality rates for FE-pICH were 27.0, 34.9 and 44.1 % at days 28, 90 and 365, respectively. In 21 patients, an (21.3 %) early do-not resuscitate-order was documented. Excluding these patients from multivariate analyses, National Institute of Health Stroke Scale (NIHSS) (OR 1.22, 95 % CI 1.08-1.36), hypercholesterolemia (OR 0.16, 95 % CI 0.05-0.55) and modified Rankin Scale (mRS) prior to stroke (OR 1.56, 95 % CI 1.06-2.3) were independently associated with risk of 1-year mortality, whereas NIHSS (OR 1.41, 95 % CI 1.20-1.66) and leukocyte count on admission (OR 1.48, 95 % CI 1.16-1.89) were independently associated with good or moderate functional outcome (mRS ≤ 3) after 1 year. Incidence of FE-ICH is in the lower range of those reported from other registries and remained stable over the observation period. Higher treatment rates for hypertension might partly account for this. Stroke severity as indicated by NIHSS was independently associated with mortality and functional outcome after 1 year. We found no association between aetiology and outcome in ICH patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812642     DOI: 10.1007/s00415-013-7013-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

2.  Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004.

Authors:  Isabelle Benatru; Olivier Rouaud; Jérôme Durier; Fabienne Contegal; Grégory Couvreur; Yannick Bejot; Guy Victor Osseby; Douraïeb Ben Salem; Frédéric Ricolfi; Thibault Moreau; Maurice Giroud
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

3.  Interrater reliability of the NIH stroke scale.

Authors:  L B Goldstein; C Bertels; J N Davis
Journal:  Arch Neurol       Date:  1989-06

4.  Do-not-resuscitate orders and predictive models after intracerebral hemorrhage.

Authors:  D B Zahuranec; L B Morgenstern; B N Sánchez; K Resnicow; D B White; J C Hemphill
Journal:  Neurology       Date:  2010-07-07       Impact factor: 9.910

5.  Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.

Authors:  Yolanda Silva; Rogelio Leira; Javier Tejada; José M Lainez; José Castillo; Antoni Dávalos
Journal:  Stroke       Date:  2004-11-18       Impact factor: 7.914

6.  Long term survival after primary intracerebral haemorrhage: a retrospective population based study.

Authors:  R Fogelholm; K Murros; A Rissanen; S Avikainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 7.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.

Authors:  Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn
Journal:  Lancet Neurol       Date:  2010-01-05       Impact factor: 44.182

8.  Approaches to the problems of measuring the incidence of stroke: the Auckland Stroke Study, 1991-1992.

Authors:  R Bonita; J B Broad; N E Anderson; R Beaglehole
Journal:  Int J Epidemiol       Date:  1995-06       Impact factor: 7.196

9.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

Authors:  P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

10.  Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.

Authors:  C E Lovelock; A J Molyneux; P M Rothwell
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more
  15 in total

1.  Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Authors:  Dionne E Swor; Matthew B Maas; Sandeep S Walia; David P Bissig; Eric M Liotta; Andrew M Naidech; Kwan L Ng
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

2.  Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage.

Authors:  Jeffrey J Fletcher; Vikas Kotagal; Aaron Mammoser; Mark Peterson; Lewis B Morgenstern; James F Burke
Journal:  Stroke       Date:  2014-12-04       Impact factor: 7.914

3.  Impact of Perihemorrhagic Edema on Short-Term Outcome After Intracerebral Hemorrhage.

Authors:  Bastian Volbers; Wolfgang Willfarth; Joji B Kuramatsu; Tobias Struffert; Arnd Dörfler; Hagen B Huttner; Stefan Schwab; Dimitre Staykov
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

4.  Risk of intracerebral haemorrhage from hypertension is greatest at an early age.

Authors:  Robert Stanton; Stacie L Demel; Matthew L Flaherty; Eleni Antzoulatos; Lee A Gilkerson; Jennifer Osborne; Tyler P Behymer; Charles J Moomaw; Padmini Sekar; Carl Langefeld; Daniel Woo
Journal:  Eur Stroke J       Date:  2021-02-08

5.  Sex Differences in the Clinical Features, Risk Factors, and Outcomes of Intracerebral Hemorrhage: a Large Hospital-based Stroke Registry in China.

Authors:  Yonghong Xing; Zhongping An; Xianghui Zhang; Ning Yu; Wenjuan Zhao; Xianjia Ning; Jinghua Wang
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

6.  Rationale and Design of a Statewide Cohort to examine efficient resource utilization for patients with Intracerebral hemorrhage (EnRICH).

Authors:  Farhaan S Vahidy; Ellie G Meyer; Arvind B Bambhroliya; Jennifer R Meeks; Charles E Begley; Tzu-Ching Wu; Jon E Tyson; Charles C Miller; Ritvij Bowry; Wamda O Ahmed; Gretchel A Gealogo; Louise D McCullough; Steven Warach; Sean I Savitz
Journal:  BMC Neurol       Date:  2018-03-21       Impact factor: 2.474

7.  Prognostic impact of leukocytosis in intracerebral hemorrhage: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Zhiyuan Yu; Jun Zheng; Rui Guo; Lu Ma; Chao You; Hao Li
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  Tight Control of Systolic Blood Pressure in Spontaneous Intraparenchymal Brain Hemorrhage.

Authors:  Mark Krel; James Brazdzionis; James G Wiginton; Dan E Miulli; Margaret Rose Wacker; Vladimir Cortez
Journal:  Cureus       Date:  2019-07-23

9.  Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012.

Authors:  Maria Carlsson; Tom Wilsgaard; Stein Harald Johnsen; Anne Merete Vangen-Lønne; Maja-Lisa Løchen; Inger Njølstad; Ellisiv Bøgeberg Mathiesen
Journal:  Cerebrovasc Dis Extra       Date:  2016-08-13

10.  Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy.

Authors:  Bernadett Fakan; Zita Reisz; Denes Zadori; Laszlo Vecsei; Peter Klivenyi; Levente Szalardy
Journal:  J Neural Transm (Vienna)       Date:  2020-03-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.